HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim Robberecht Selected Research

Prolyl Hydroxylases (Prolyl Hydroxylase)

2/2016Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wim Robberecht Research Topics

Disease

39Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020 - 06/2003
10Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 06/2004
9Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2018 - 04/2008
8Frontotemporal Dementia (Semantic Dementia)
01/2020 - 04/2008
6Motor Neuron Disease (Primary Lateral Sclerosis)
12/2019 - 10/2004
5Stroke (Strokes)
01/2020 - 09/2007
4Disease Progression
12/2019 - 06/2004
3Polyneuropathies (Polyneuropathy)
01/2019 - 01/2009
3Atrophy
01/2019 - 08/2003
3Neoplasms (Cancer)
01/2018 - 11/2013
3Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2018 - 06/2004
2Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2020 - 01/2020
2Alzheimer Disease (Alzheimer's Disease)
12/2019 - 12/2010
2Paralysis (Palsy)
01/2019 - 01/2005
2Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
01/2019 - 06/2013
2Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 01/2018
2Inflammation (Inflammations)
01/2016 - 11/2013
2Disease Susceptibility (Diathesis)
09/2014 - 06/2012
2Body Weight (Weight, Body)
06/2013 - 08/2003
1Fragile X Tremor Ataxia Syndrome
01/2020
1Myotonic Dystrophy (Dystrophia Myotonica)
01/2020
1Huntington Disease (Huntington's Disease)
01/2020
1Seizures (Absence Seizure)
01/2020
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1Dysarthria (Spastic Dysarthria)
10/2017
1Dyspepsia (Indigestion)
01/2017
1Respiratory Insufficiency (Respiratory Failure)
01/2017
1Transitional Cell Carcinoma
01/2017
1Dementia (Dementias)
01/2017
1Ischemic Stroke
02/2016
1Cerebral Infarction
02/2016
1Ischemia
02/2016
1Sudden Death
06/2014
1Isaacs Syndrome (Neuromyotonia)
06/2014
1Gliosis
12/2013
1Hypoventilation
03/2013
1Parkinson Disease (Parkinson's Disease)
12/2011
1Type 2I Charcot-Marie-Tooth disease
08/2010
1Guillain-Barre Syndrome
05/2010
1Sarcoma (Soft Tissue Sarcoma)
10/2009

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
12/2019 - 06/2004
8ProgranulinsIBA
01/2017 - 04/2008
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 08/2003
6DNA-Binding Proteins (DNA Binding Protein)IBA
10/2018 - 08/2009
6AMPA Receptors (AMPA Receptor)IBA
12/2010 - 06/2003
4Biomarkers (Surrogate Marker)IBA
08/2016 - 05/2009
4Superoxide Dismutase-1IBA
01/2013 - 03/2005
3propionic acid (potassium propionate)IBA
12/2010 - 06/2003
2RNA (Ribonucleic Acid)IBA
01/2020 - 05/2010
2Pharmaceutical PreparationsIBA
01/2020 - 01/2017
2NucleotidesIBA
01/2020 - 06/2014
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2019 - 06/2013
2Glycine-tRNA LigaseIBA
01/2018 - 05/2008
2Histone Deacetylase 6IBA
01/2018 - 01/2018
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2018 - 10/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2013 - 12/2010
2IonsIBA
12/2010 - 09/2007
2Small Heat-Shock ProteinsIBA
08/2010 - 06/2004
2UbiquitinIBA
03/2010 - 08/2009
1polyglutamineIBA
01/2020
1Amyloid (Amyloid Fibrils)IBA
12/2019
1EphrinsIBA
12/2019
1Ephrin-A5 (AL-1)IBA
12/2019
1GlycosyltransferasesIBA
01/2019
1HizentraIBA
01/2019
1Immunoglobulins (Immunoglobulin)IBA
01/2019
1Jagged-1 ProteinIBA
11/2018
1Vincristine (Oncovin)FDA LinkGeneric
01/2018
1TubulinIBA
01/2018
1Vinca AlkaloidsIBA
01/2018
1Arginine (L-Arginine)FDA Link
03/2017
1ricolinostatIBA
01/2017
1ozanezumabIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
08/2016
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
02/2016
1OligonucleotidesIBA
02/2016
1Oxygen (Dioxygen)IBA
02/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2016
1Interleukin-6 (Interleukin 6)IBA
01/2016
1LipopolysaccharidesIBA
01/2016
1Biological ProductsIBA
12/2014
1KinesinsIBA
10/2014
1PrionsIBA
06/2014
1Histidine (L-Histidine)FDA Link
06/2014
1Carrier Proteins (Binding Protein)IBA
06/2014
1Proline (L-Proline)FDA Link
06/2013
1fasudil (AT 877)IBA
06/2013
1polyalanineIBA
06/2012
1angiogeninIBA
12/2011
1alpha-Crystallins (alpha-Crystallin)IBA
08/2010
1AntibodiesIBA
05/2010
1DNA (Deoxyribonucleic Acid)IBA
10/2009
1Glatiramer Acetate (Copaxone)FDA Link
10/2009

Therapy/Procedure

11Therapeutics
01/2020 - 10/2003
2Noninvasive Ventilation
04/2015 - 03/2013
1Catheters
01/2020
1Muscle Denervation
01/2019
1Drug Therapy (Chemotherapy)
01/2018
1Speech Therapy (Therapy, Speech)
10/2017